Thursday, December 9, 2021

Bloom Science Scores $12M

San Diego=based Bloom Science, a biotech startup developing microbiome-based treatments for neurological and inflammatory disease, says it has raised $12M in its Series A funding. The funding was led by Leaps by Bayer, the impact investment arm of Bayer AG, and the ALS Investment Fund, and also included Apollo Health Ventures, plus existing investo

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.